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AbsTrACT
Objective Obesity is a risk factor for non-alcoholic 
steatohepatitis (naSH). this risk has been attributed to 
visceral adipose tissue (vat) expansion associated with 
increased proinflammatory mediators. accumulation of 
cD11c+ proinflammatory adipose tissue macrophages 
(atM) is an important driver of vat inflammation. We 
investigated the role of atMs in hepatic inflammation 
during naSH development.
Design vat isolated from lean, obese or atM 
-depleted (using clodronate liposomes) obese mice was 
transplanted to lean ldlr-/- acceptor mice. Systemic and 
hepatic inflammation was assessed either after 2 weeks 
on standard chow or after 8 weeks on high cholesterol 
diet (HcD) to induce naSH.
results transplanting donor vat from obese mice 
increased HcD-induced hepatic macrophage content 
compared with lean-transplanted mice, worsening liver 
damage. atM depletion prior to vat transplantation 
reduced this increased hepatic macrophage 
accumulation. On chow, vat transplantation induced 
a more pronounced increase in circulating and hepatic 
neutrophil numbers in obese-transplanted than  
lean-transplanted mice, while atM depletion prior to vat 
transplantation reversed this effect. Microarray analysis 
of fluorescence-activated cell sorting of cD11c+ and 
cD11c− macrophages isolated from donor adipose tissue 
showed that obesity resulted in enhanced expression 
of neutrophil chemotaxis genes specifically in cD11c+ 
atMs. involvement of the neutrophil chemotaxis proteins, 
cXcl14 and cXcl16, was confirmed by culturing vat. in 
humans, cD11c expression in vat of obese individuals 
correlated with vat expression of neutrophil chemotactic 
genes and with hepatic expression of neutrophil and 
macrophage marker genes.
Conclusion atMs from obese vat induce hepatic 
macrophage accumulation during naSH development, 
possibly by enhancing neutrophil recruitment.
InTrODuCTIOn
Obesity has become a major health burden and is 
considered a key risk factor for diseases such as 
diabetes, non-alcoholic fatty liver disease (NAFLD) 
and a plethora of cardiovascular diseases (CVD).1 2 
This increased risk has been mainly attributed to the 
expansion of visceral adipose tissue (vAT), which is 
associated with inflammation. Lipid accumulation 
in the liver, known as steatosis, is present in the 
majority of obese subjects, of which 30% have biop-
sy-proven non-alcoholic steatohepatitis (NASH).3 
NASH is the most progressive form of NAFLD and 
is characterised by steatosis accompanied by inflam-
mation causing irreversible liver damage and hepatic 
fibrosis. Extensive fibrosis can lead to cirrhosis, 
requiring patients to undergo a liver transplanta-
tion. Moreover, hepatic inflammation increases 
the risk of developing hepatocellular carcinoma 
and increases CVD risk.4 5 Hepatic macrophages or 
Kupffer cells play a major role in liver inflammation 
and are thought to be triggered by an abundance of 
liver fat and factors such as inflammatory cytokines, 
oxidative stress, advanced glycation end-products 
and cholesterol.6 7 However, the exact triggers of 
hepatic inflammation are not yet understood.
Compared with other adipose tissue (AT) depots, 
vAT is considered the main contributor to NAFLD 
development. Due to its anatomic proximity to 
the liver and due to the fact that venous drainage 
from vAT happens via the portal system, vAT 
could directly deliver fatty acids and inflammatory 
mediators to the liver.8 Moreover, portal drainage 
of AT grafts has been shown to influence insulin 
sensitivity, possibly affecting NAFLD develop-
ment.9 Furthermore, the chronic systemic inflam-
mation associated with vAT expansion may also 
contribute to hepatic inflammation. During obesity, 
adipose tissue macrophages (ATM) accumulate in 
the vAT of mice and humans.10 11 In addition to 
their elevated numbers, ATM phenotype changes 
during obesity development. vAT from lean subjects 
typically contains more mannose receptor C-type 
1 positive (MRC1+) CD11c− macrophages 
frequently described as ‘alternatively activated’ 
anti-inflammatory M2 macrophages. In comparison, 
vAT from obese individuals has an abundance of 
‘classically activated’ proinflammatory CD11c+ M1 
macrophages, which produce high levels of TNF, 
iNOS and IL12. CD11c+ macrophages are typically 
found in crown-like structures surrounding dead 
adipocytes, are associated with insulin resistance and 
may contribute to systemic chronic inflammation.10 
However, whether CD11c+ macrophages directly 
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contribute to NASH is unknown. Tordjman et al demonstrated 
a positive association between visceral ATM numbers and liver 
histopathology (steatosis, fibrosis and inflammation score) in 
morbidly obese subjects.12 However, which macrophage subset 
underlies this association and whether macrophages are causally 
linked to NASH development is unknown. In the current study, 
we investigated whether ATMs directly cause hepatic inflam-
mation during NASH development. To achieve this, lean mice 
were transplanted with vAT from either lean donor mice, obese 
donor mice or obese donor mice from which ATMs in vAT tissue 
were depleted prior to transplantation. This experimental set-up 
allowed us to investigate whether hepatic inflammation was 
affected by transplanting AT of obese mice compared with trans-
planting AT of lean mice. In addition, the exact contribution of 
ATMs was assessed by depleting ATMs prior to transplantation. 
Our study reveals a key role of ATMs in hepatic inflammation 
by amplifying macrophage accumulation in established NASH, 
possibly via inducing early neutrophil infiltration.
MATerIAls AnD MeTHODs
Additional materials and methods are included in the online 
supplementary information.
AT transplantation
Epididymal AT derived from male donor C57BL/6 ldlr-/- CD45.1 
mice fed a low-fat diet (LFD), high-fat diet (HFD) or HFD in 
combination with clodronate liposomes injection was trans-
planted to male C57BL/6 CD45.2 congenic ldlr-/- mice resulting 
in three groups: lean-transplanted acceptors (LTA), obese-trans-
planted acceptors (OTA) and ATM-depleted obese-transplanted 
acceptors (DOTA). In the first experiment, hepatic steatosis 
and inflammation were induced in ldlr-/- acceptor mice with a 
high-cholesterol diet (HCD) for 4 weeks before and 8 weeks after 
AT transplantation.13 14 In the second experiment, all acceptor 
mice received standard chow for 2 weeks.
Flow cytometry
AT and liver tissues were digested and bone marrow (BM) was 
flushed from the femur and tibia. Single cell suspensions were 
stained with a cocktail of antibodies (see online supplementary 
table 1 and supplementary figures 1 and 2).
rnA isolation, cDnA synthesis and qrT-PCr
RNA was isolated from murine vAT and liver for cDNA synthesis 
followed by quantitative PCR. Primer sequences are given in 
online supplementary table 2.
Histology
Frozen murine liver sections were stained with either oil red O 
or with antibodies against macrophages (F4/80), T cells (CD3), 
monocytes/neutrophils (CD11b) and neutrophils (NIMP) as 
previously described.13 15 Paraffin-embedded vAT and liver 
sections were stained for H&E or Sirius red to assess hepatic 
steatosis and fibrosis.
liver and plasma cholesterol and triglyceride measurements
Cholesterol and triglycerides were measured in liver homoge-
nates and plasma as described previously.16
Cytokine levels
AT homogenates of donor AT were used to measure cytokine 
levels of MCP1, interleukin (IL)-6, chemokine (C-X-C motif) 
ligand1 (CXCL1), interferon-gamma (IFN-γ), IL-1β, IL-2, IL-4, 
IL-5, IL-10, IL-12P70 and tumour necrosis factor (TNF) according 
to the manufacturer’s instructions.
AT culturing 
vAT explants from the three donor groups were cultured. Lipo-
polysaccharide-induced CXCL14 and CXCL16 secretion were 
measured using ELISA, following manufacturer’s instructions.
CD11c− and CD11c+ cell sorting and array
By using fluorescence-activated cell sorting (FACS), CD11c+ and 
CD11c− ATMs were isolated from mice fed either LFD or HFD 
for 12 weeks for microarray analysis. Data are presented as fold 
change (FC) in expression level compared with LFD-fed mice. 
significance of this study
What is already known on this subject?
 ► Obesity is characterised by adipose tissue dysfunction 
resulting in increased adipose tissue inflammation, which can 
cause systemic inflammation.
 ► Obese adipose tissue is rich in CD11c+ macrophages which are 
proinflammatory and contribute to adipose tissue inflammation.
 ► A positive association between visceral adipose tissue (vAT) 
macrophage numbers and liver histopathology (steatosis, fibrosis 
and inflammation score) has been shown in morbidly obese 
subjects.
What are the new findings?
 ► The proinflammatory CD11c+ macrophages that accumulate 
in obese adipose tissue express high levels of neutrophil 
chemotaxis genes resulting in elevated secretion of 
neutrophil chemotaxis proteins, such as CXCL14 and CXCL16, 
by obese adipose tissue.
 ► The CD11c+ adipose tissue macrophages recruit neutrophils from 
bone marrow resulting in elevated circulating neutrophil levels 
and consequently increased hepatic neutrophil accumulation.
 ► In an experimental model of non-alcoholic 
steatohepatitis (NASH), transplanting obese adipose tissue 
caused increased hepatic macrophage accumulation worsening 
liver damage.
 ► CD11c expression, as a marker of proinflammatory macrophages, 
was associated with neutrophil chemotaxis gene expression 
in human vAT biopsies. In addition, vAT CD11c expression also 
correlated with gene expression of neutrophil and macrophage 
markers in paired human liver biopsies.
How might it impact on clinical practice in the foreseeable 
future?
 ► Our data again show the need to tackle adipose tissue 
inflammation as it seemingly contributes directly to 
complications such as NASH. More awareness regarding 
this subject is necessary and medication targeting systemic 
inflammation might be a treatment option.
 ► By revealing targetable proteins involved in the initiation 
of hepatic inflammation in obesity, such as the proposed 
neutrophil chemotaxis genes, specific inhibitors could be 
developed that might prevent effects of adipose tissue 
inflammation on systemic inflammation and thus the liver.
 ► For definitive diagnosis of NASH, an invasive liver biopsy 
is currently still required. Measuring a panel of circulating 
inflammatory proteins (chemokines) linked to hepatic 
inflammation would be a vast improvement.
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Genes showing FCs of at least 1.50 and a p value of less than 
0.05 were considered differentially regulated.
Human vAT and liver gene expression data
vAT and liver microarray data were obtained from vAT and liver 
biopsies which were taken from 74 patients who are morbidly 
obese (body mass index 35–70) (see online supplementary table 
3). Correlations were tested by calculating Pearson’s correlation 
coefficient using SPSS statistics V.23 (IBM). After Bonferroni 
correction to adjust for multiple testing, p values of ≤0.004 were 
deemed statistically significant. The population was divided into 
non-NASH (score of ≤4) and NASH (a score of ≥5) based on 
the NAFLD activity score (NAS).
resulTs
CD11c+ macrophages accumulate in vAT and correlate with 
hepatic macrophage content
Before transplanting vAT to lean acceptor mice, we examined 
the effect of HFD feeding and clodronate-mediated macro-
phage depletion on AT phenotype in non-transplanted mice. 
Compared with LFD-fed mice, 16 weeks of HFD feeding 
increased body weight over 80% and vAT and subcutaneous 
AT (scAT) weights (see online supplementary figure 3A,B). 
Total immune cell levels were elevated in vAT but not scAT 
(see online supplementary figure 3C). HFD induced expres-
sion levels of Cd11c, Mcp1 (proinflammatory chemokine), 
Tnf (proinflammatory cytokine) and F4/80 (general macro-
phage marker) suggesting CD11c+ macrophage accumulation 
(figure 1A). Flow cytometry analysis revealed a large increase 
in CD11c+ macrophages while CD11c− macrophages were 
increased to a lesser extent. Levels of CD4+ T cells were 
decreased in vAT by HFD feeding while other immune cells 
were unaffected (figure 1B). Interestingly, liver macrophage 
content correlated significantly with CD11c+ macrophages 
in vAT but not with CD11c− ATMs (figure 1C). Liver macro-
phages did not correlate with dendritic cells (DC), CD8+ 
T cells, B cells or granulocytes, but did show a negative 
correlation with CD4+ T cells and natural killer cells in vAT 
(see online supplementary figure 3D). These results suggest 
that CD11c+ ATM numbers are linked to liver macrophage 
content.
Figure 1 Diet-induced obesity induces accumulation of CD11c+ macrophages in visceral adipose tissue which correlates with hepatic macrophages. 
(A) Gene expression levels of Cd11c, Mcp1, Tnf and F4/80 in visceral adipose tissue (vAT) of mice fed LFD or HFD for 16 weeks. (B) CD11c− and 
CD11c+ macrophages, dendritic cells (DC), CD8+ T cells, CD4+ T cells and B cells were determined by flow cytometry and are displayed as percentage 
of live cells in vAT of LFD and HFD-fed mice. (C) Correlations of CD11c+ or CD11c− ATMs with liver macrophages measured with flow cytometry. All 
data are means±SEM; n=7 per group. *p<0.05, **p<0.01, ***p<0.001 versus LFD. Spearman's rank correlations based on n=14. ATM, adipose tissue 
macrophage; HFD, high-fat diet; LFD, low-fat diet.
copyright.
 on O
ctober 29, 2020 at U
niversity of M
aastricht C
onsortia. P
rotected by
http://gut.bm
j.com
/
G
ut: first published as 10.1136/gutjnl-2016-313654 on 26 O
ctober 2017. D
ow
nloaded from
 
1320 Bijnen M, et al. Gut 2018;67:1317–1327. doi:10.1136/gutjnl-2016-313654
Hepatology
Clodronate liposomes deplete ATMs from vAT of obese mice
Clodronate liposomes blunted the induction of F4/80 and 
Cd11c expression by HFD feeding (figure 2A). Additionally, 
clodronate liposomes reduced levels of CD11c− macrophages 
and normalised levels of CD11c+ macrophages in obese mice 
to levels observed in LFD-fed mice without affecting CD11c+ 
DCs (figure 2B). In agreement, crown-like structures, containing 
CD11c+ cells,17 were nearly absent after clodronate liposome 
injection (figure 2C). ATM depletion resulted in a decrease in 
Tnf and Ifn-γ (macrophage activating cytokine) gene expression, 
without affecting expression levels of other cytokines such as 
IL10 (anti-inflammatory cytokine), IL1β (mediator inflamma-
tory response), IL6 (proinflammatory cytokine), Fractalkine 
(chemokine and leucocyte adhesion) and Cxcl1 (chemotaxis) 
(figure 2D). In line, ATM depletion did not affect vAT IL6 and 
CXCL1 protein levels, while MCP1 protein levels were reduced 
(figure 2E). Two days after clodronate injection, circulating 
monocyte levels were normalised, suggesting that that all injected 
clodronate liposomes were phagocytosed already one day after 
injection (see online supplementary figure 4A).
ATMs induce hepatic macrophage accumulation in nAsH
All acceptor ldlr-/- mice received an HCD to induce NASH for 
4 weeks before and 8 weeks after transplantation of donor vAT 
generating the following groups: LTA, OTA and DOTA. Body 
Figure 2 Clodronate liposomes deplete adipose tissue macrophages (ATM) from obese visceral adipose tissue (vAT). (A, B) Gene expression levels 
of F4/80 and Cd11c (A) and CD11c− and CD11c+ macrophages and DC numbers displayed as percentage of live cells determined by flow cytometry 
(B) in vAT of mice fed LFD, HFD or HFD and injected with clodronate liposomes 48 hours before sacrifice (HFD+C). (C) Representative pictures of the 
vAT stained with H&E (100× magnification), arrows show crown-like structures (CLSs) and quantification of these structures. (D, E) Gene expression 
(D) and protein levels (E) of inflammatory markers in the vAT. All data are means±SEM; Panel A, D: n=13-14 per group. Panel B, C, E: n=4–6 per group. 
*p<0.05, **p<0.01, ***p<0.001 versus LFD. #p<0.05, ##p<0.01, ###p<0.001 versus HFD. CLS, crown-like structure; DC, dendritic cell; HFD, high-fat 
diet; HFD+C, HFD and injected with clodronate liposomes; IL, interleukin; LFD, low-fat diet; nd, not detectable.
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weight development in response to the HCD and surgery was 
comparable between the experimental groups, indicating equal 
recovery (see online supplementary figure 5A). Transplanted AT 
was examined at the end of the experiment. Transplanted AT 
was well vascularised via the peritoneum in each mouse (data 
not shown). In addition, transplanted AT weight (see online 
supplementary figure 4B), morphology and necrosis (data not 
shown) were similar between groups. Moreover, F4/80 and 
CD11c expression levels of transplanted AT were not signifi-
cantly different between groups 2 or 8 weeks after transplanta-
tion (see online supplementary figure 4C,D). Experiments were 
performed using CD45.1 donor and CD45.2 acceptor mice. 
These isoforms of CD45 allowed us to distinguish donor and 
host cells, but do not differ in functionality. CD45.1+ donor cells 
were absent in the circulation (see online supplementary figure 
5B), liver, spleen, AT and draining lymph nodes of CD45.2 
acceptor mice post-transplantation (data not shown), excluding 
effects of direct migration of donor cells into host tissue. Due 
to the HCD, circulating monocyte and neutrophil levels were 
elevated before vAT transplantation (t=0).18 19 vAT transplan-
tation did not further affect blood monocytes in LTA mice. 
Interestingly, blood monocytes were decreased in OTA mice, 
while this effect was not observed in DOTA mice (see online 
supplementary figure 5C). A similar trend was seen for both 
Ly6c− (patrolling) and Ly6c+ (inflammatory) monocyte subsets 
(data not shown). Circulating neutrophil levels were unchanged 
8 weeks after AT transplantation (see online supplementary 
figure 5C).
Next, we investigated whether NASH development was 
affected in OTA or DOTA mice. Liver triglycerides and choles-
terol measurements as well as H&E and oil red O stained liver 
sections showed equal steatosis between the groups (figure 3A,C, 
see online supplementary figure 5D,E). Hepatic neutrophil and 
T cell numbers did not differ between the groups (figure 3B). 
Strikingly, hepatic macrophage content was increased in the 
OTA mice compared with LTA mice while this was not observed 
in the DOTA mice (figure 3D). In line, hepatic F4/80 expres-
sion was lower in DOTA mice compared with OTA mice. Other 
inflammatory genes, such as Mcp1, Tnf, Mpo (Myeloperoxidase; 
neutrophil activation marker), Cd11b (myeloid marker present 
on neutrophils, monocytes and macrophages), and Ly6c (proin-
flammatory monocyte marker) and Col1a1 (fibrosis marker), 
were not different between the groups (figure 3E). Staining 
with Sirius red to visualise fibrosis revealed mild fibrosis which 
did not differ between the groups (data not shown). Compared 
with LTA mice, circulating alanine aminotransferase (ALAT) 
levels were strongly increased in OTA mice, but not in DOTA 
mice (figure 3F). Plasma glucose and insulin levels did not differ 
between groups suggesting no effects on insulin resistance (data 
not shown). These findings indicate that ATMs induce hepatic 
macrophage accumulation in NASH contributing to hepatic 
damage.
ATMs rapidly induce the recruitment of hepatic neutrophils
To investigate the mechanisms responsible for increased hepatic 
macrophage accumulation in OTA mice, we studied the initi-
ating events by performing a short-term study. Again, vAT 
transplantation was performed to generate LTA, OTA or DOTA 
mice which were maintained on a chow diet. Compared with 
OTA mice, hepatic expression of the neutrophil marker MPO 
and of the myeloid marker Cd11b was decreased in DOTA mice 
suggesting decreased hepatic neutrophil infiltration. S100A8 
(involved in neutrophil recruitment) expression levels tended 
to be decreased in DOTA mice. No difference was observed in 
inflammation and macrophage-related markers such as F4/80, 
Mcp1, Tnf and Ly6c (figure 4A). Flow cytometry data showed a 
clear accumulation of hepatic neutrophils in OTA mice compared 
with LTA mice and confirmed the reduction of hepatic neutro-
phils in DOTA mice (figure 4B). Immunohistochemistry showed 
a similar but non-significant trend in hepatic neutrophil count 
(figure 4C,D) while CD11b+ cells were increased in OTA mice 
but not in DOTA mice (figure 4E). At this time point, there was 
no difference in F4/80+ tissue macrophages (figure 4F). In line, 
there were no differences in either plasma ALAT (figure 4G) or 
lipid levels, or in hepatic lipid levels (see online supplementary 
figure 6A,B). To assess whether lipolysis was affected in donor 
vAT, gene expression of lipolysis genes (hormone sensitive lipa-
seand lipoprotein lipase) in the transplanted AT as well as circu-
lating free fatty acids were measured. No differences were found 
between groups (data not shown). Compared with LTA mice, 
OTA mice displayed elevated circulating neutrophils after vAT 
transplantation whereas in DOTA mice circulating neutrophils 
decreased (figure 5A). Circulating monocytes showed a trend 
towards increased levels in LTA and OTA but not in DOTA mice 
(figure 5A). These results suggest that ATMs stimulate neutrophil 
recruitment, possibly from bone marrow (BM). Therefore, using 
flow cytometry, we determined levels of BM progenitor cells. 
Common myeloid progenitor (CMP) cells were higher in OTA 
and DOTA mice, although not statistically significant. Granulo-
cyte-macrophage progenitor cells, which are derived from CMPs 
and are neutrophil precursors,20 were lower in the DOTA mice 
compared with the OTA mice (figure 5B), suggesting that ATMs 
from obese vAT stimulate neutrophil development in BM.
To determine the mechanism by which ATMs induce neutro-
phil recruitment, we sorted CD11c+ and CD11c− macrophages 
from vAT derived from LFD and HFD-fed mice (similar to donor 
mice). Microarray analysis was performed to investigate qualita-
tive differences in ATMs induced by obesity. Interestingly, several 
genes involved in neutrophil chemotaxis, such as members of the 
CXCL and colony stimulating factor (CSF) families, were specif-
ically upregulated only in CD11c+ ATMs in response to high fat 
feeding (figure 5C): Cxcl14 (FC=2.47), Cxcl16 (FC=2.01) and 
Gm-csf (FC=1.67). Cxcl1 was increased significantly in both 
CD11c+ (FC=1.84) and CD11c− (FC=2.14) cells after HFD 
feeding. In total vAT, HFD feeding increased gene expression 
of CXCL14 and CXCL16. Depletion of ATMs using clodronate 
reduced both CXCL14 and CXCL16 expression, but this reduc-
tion was only significant for CXCL14 (see online supplementary 
figure 7A). Taken together, these data show that, in addition 
to their accumulation in vAT during obesity, CD11c+ cells 
feature enhanced expression of neutrophil chemoattractants. 
Finally, culturing vAT from the three different types of donor 
mice showed that CXCL14 and CXCL16 protein secretion is 
induced in vAT from obese mice and ATM depletion normalised 
this secretion to the levels observed in vAT from lean animals 
(figure 5D). These results suggest that ATMs are responsible for 
the secretion of neutrophil chemoattractants by vAT.
Human CD11c expression in vAT correlates with liver 
neutrophil and macrophage markers
To investigate if our findings were translatable to human liver 
disease, we analysed hepatic and vAT transcriptomic data of 
bariatric surgery patients (see online supplementary table 3). 
Based on the NAFLD activity score (NAS), subjects were divided 
into non-NASH (NAS≤4) patients and patients with NASH 
(NAS≥5). Although all patients displayed morbid obesity, gene 
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expression of CXCL5, CXCL16 and M-CSF was only increased in 
patients who are obese with NASH. Other inflammatory genes, 
including CD11c, tended to be higher in patients who are obese 
with NASH (see online supplementary table 4). Next, we inves-
tigated whether macrophage markers in vAT correlated with 
macrophage and neutrophil markers in the livers of the same indi-
viduals (table 1). CD11c gene expression was used as a marker 
of CD11c+ ATMs, while for CD11c− ATMs, we analysed MRC1, 
a known marker of alternatively activated resident CD11c− AT 
macrophages.10 CD11c expression in vAT correlated with hepatic 
expression of the neutrophil markers MPO (R=0.331; p=0.004) 
and CD15 (R=0.328; p=0.004).21 22 We did not find a correla-
tion between MRC1 in vAT and hepatic MPO, CD15 or CD11b 
expression. CD11c in vAT did not correlate with hepatic FCGR2A 
(R=0.246; p=0.035), a general macrophage marker, or with 
MRC1 (R=0.061; p=0.608), but did show a strong correlation 
with hepatic CD11c expression (R=0.426; p=0.000). vAT MRC1 
did not correlate with any of these markers in the liver.
Next, we studied the association of CD11c or MRC1 in vAT 
with neutrophil chemotaxis genes in vAT. Strong correlations 
Figure 3 Adipose tissue macrophages induce hepatic macrophage accumulation in non-alcoholic steatohepatitis (NASH). (A, C) Liver triglyceride 
and cholesterol levels (A) including representative photos (200× magnification) of the H&E stained liver sections (C) of LTA, OTA and DOTA mice fed 
a high-cholesterol diet (HCD) for a total of 12 weeks. (B) Quantification of immunohistochemical staining of hepatic neutrophil and T cell numbers 
in the LTA, OTA and DOTA mice. (D) Representative photos of the LTA, OTA and DOTA mice livers stained for F4/80 (200× magnification) and the 
corresponding quantification. (E) Hepatic gene expression levels of inflammatory, immune cell-specific and fibrotic markers. (F) Circulating ALAT levels. 
All data are means±SEM; n=9–12 per group. *p<0.05 versus LTA. **p<0.05 versus LTA. #p<0.05 versus OTA. ALAT, alanine aminotransferase; DOTA, 
ATM-depleted obese-transplanted acceptors; LTA, lean-transplanted acceptors; ns, not significant; OTA, obese-transplanted acceptors.
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were found between CD11c and CXCL2 (R=0.695; p=0.000), 
CXCL5 (R=0.565; p=0.000), CXCL8 (human homologue of 
murine CXCL1; R=0.736; p=0.000), CXCL16 (R=0.504; 
p=0.000), S100A8 (R=0.813; p=0.000) and G-CSF 
(R=0.702; p=0.000), but not with GM-CSF (R=−0.016; 
p=0.895) or M-CSF (R=0.069; p=0.559). Conversely, MRC1 
did not correlate with any of the chemotaxis markers (table 2). 
Although numerically outnumbered by ATMs, DCs also 
express CD11c. vAT expression of the DC marker gene FLT3 
did not correlate with any of the investigated genes in the 
liver and only correlated with CXCL5 (R=0.355; p=0.002) 
in the vAT (see online supplementary tables 5 and 6), arguing 
against DC involvement.23 Taken together, these findings are 
in line with our data showing that CD11c+ macrophages in 
vAT mediate the increased neutrophil chemotaxis and hepatic 
inflammation.
Figure 4 Hepatic neutrophil infiltration is triggered by adipose tissue macrophages. (A, B) Hepatic gene expression levels of inflammatory markers 
(A) and liver neutrophil levels measured by fluorescence-activated cell sorting (FACS) (B) in LTA, OTA and DOTA mice 2 weeks after transplantation 
and fed a standard chow diet. (C, D) Representative pictures of hepatic neutrophil staining (200× magnification, arrows show positive cells) (C) and 
corresponding quantification (D). (E, F) Quantification of CD11b positive cells (E) and F4/80 staining (F) in the liver. (G) Plasma ALAT levels. All data 
are means±SEM; n=4–5 per group. *p<0.05, **p<0.01 versus LTA. #p<0.05 versus OTA. ALAT, alanine aminotransferase; DOTA, ATM-depleted obese-
transplanted acceptors; LTA, lean-transplanted acceptors; OTA, obese-transplanted acceptors.
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DIsCussIOn
Our study shows that transplantation of AT from obese mice 
rapidly causes elevated circulating neutrophils and hepatic 
neutrophil infiltration. Increased expression of genes involved 
in neutrophil recruitment, in CD11c+ ATMs, probably 
contributes to hepatic neutrophil accumulation. Furthermore, 
in an experimental model of NASH, transplanting CD11c+ 
ATM-rich AT of obese mice resulted in more hepatic macro-
phage accumulation and enhanced liver damage. Depleting 
ATMs from obese donor AT prior to transplantation inhib-
ited the effects on neutrophil and macrophage accumulation, 
indicating that CD11c+ ATMs directly contribute to hepatic 
inflammation. Lastly, CD11c expression was associated with 
neutrophil chemotaxis gene expression in human AT biopsies. 
Figure 5 CD11c+adipose tissue macrophages (ATM) increase circulating neutrophils and their recruitment from the bone marrow. (A) Circulating 
neutrophils and monocytes before and 12 days after AT transplantation in LTA, OTA and DOTA mice on a chow diet. (B) Bone marrow fluorescence-
activated cell sorting (FACS) data displaying CMP and GMP cells as percentage of live bone marrow cells 2 weeks after transplantation. (C) 
Fold changes (FC) in gene expression of a cluster of genes involved in neutrophil chemotaxis in CD11c+ and CD11c− macrophages after HFD 
feeding. All data are means±SEM; n=4–5 per group. *p<0.05 versus LTA. #p<0.05, ##p<0.01 versus OTA. $FC≥1.50 and p<0.05 was considered 
differentially regulated. (D) CXCL14 and CXCL16 protein levels measured in medium after culturing adipose tissue derived from donor mice 
expressed as pg produced per mg AT. n=4–6. Representative data shown of experiment, which was performed three times. All data are means±SEM; 
***p<0.001 versus LFD. #p<0.05, ##p<0.01 versus HFD. CMP, common myeloid progenitor cells; DOTA, ATM-depleted obese-transplanted acceptors; 
GMP, granulocyte-macrophage progenitor cells; HFD, high-fat diet; HFD+C, HFD and injected with clodronate liposomes; LFD, low-fat diet; LTA, lean-
transplanted acceptors; OTA, obese-transplanted acceptors.
Table 1 Correlations of CD11c and MRC1 expression in human vAT with neutrophil and macrophage markers in the liver
MPO (liver) CD15 (liver) CD11b (liver) FCGr2A (liver) CD11c (liver) MrC1 (liver)
CD11c (vAT) R value 0.331* 0.328* 0.160 0.246 0.426* 0.061
p Value 0.004 0.004 0.173 0.035 0.000 0.608
MRC1 (vAT) R value −0.185 0.001 −0.023 −0.016 0.057 0.025
p Value 0.114 0.993 0.845 0.890 0.629 0.832
R values and corresponding p values of the Pearson’s correlations between CD11c and MRC1 in vAT with MPO, CD15, CD11b, FCGR2A, CD11c and MRC1 in liver. n=74.
*p≤0.004 was deemed statistically significant due to adjustment for multiple testing.
vAT, visceral adipose tissue.
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Strikingly, AT CD11c expression also correlated with gene 
expression of neutrophil and macrophage markers in paired 
human liver biopsies.
Previously, it has been shown that visceral ATM numbers and 
liver histopathology (steatosis, fibrosis and inflammation score) 
are associated in morbidly obese subjects.12 Using FACS anal-
ysis on murine AT, we now show that specifically CD11c+, but 
not CD11c−, macrophages are associated with hepatic macro-
phages. Moreover, our microarray data in human AT and liver 
biopsies confirm this link between CD11c+ ATMs and hepatic 
pathophysiology.
Transplanting AT from obese mice, rich in CD11c+ macro-
phages, to non-hypercholesteraemic mice rapidly resulted in 
elevated circulating and hepatic neutrophil levels, but not when 
transplanting AT from obese mice from which ATMs were 
depleted prior to transplantation. A potential role of neutro-
phils in NASH has been previously suggested as MPO-deficient 
mice have reduced hepatic inflammation and attenuated NASH 
development.24 However, the increase in hepatic neutrophil 
accumulation we observed 12 days after AT transplantation did 
not coincide with macrophage accumulation or elevated liver 
enzyme levels. Neutrophils are the first cell type to be recruited 
in response to infections or damage, followed by monocyte 
recruitment and macrophage accumulation to tissues.25 Hence, it 
is possible that neutrophil recruitment is a primary event leading 
to further liver inflammation. In line, our data show that during 
NASH development, AT from obese mice enhanced hepatic 
macrophage accumulation in acceptor mice and increased circu-
lating liver enzyme levels, suggesting enhanced liver damage. 
Again, these effects were mediated by obesity-induced ATMs 
since depletion of ATMs before transplantation did not increase 
macrophage accumulation or ALAT levels. Collectively, these 
data suggest a certain sequence of events where ATMs trigger 
the recruitment of neutrophils via enhanced production of 
chemokines, leading to their accumulation in the liver. Next, 
these acute events probably lead to hepatic macrophage accu-
mulation resulting in liver damage. In line, Nagareddy et al 
previously showed that ATMs can mediate BM production of 
neutrophils.26 Moreover, disrupting inflammatory signalling in 
CD11c expressing cells decreased circulating neutrophil and 
neutrophil precursor levels in BM. These data argue in favour 
of a causal role for CD11c+ macrophages.26 By performing 
microarray analysis on sorted CD11c+ and CD11c− cells derived 
from AT of lean and obese mice, we now accurately determined 
gene expression of chemoattractant proteins in specific macro-
phage populations instead of in whole AT. Our data showed an 
increased expression of neutrophil chemotaxis genes in specifi-
cally CD11c+ macrophages. Most of the upregulated genes in 
CD11c+ macrophages belong to the CXCL chemokine family 
which are known to primarily attract neutrophils.27 In partic-
ular, CXCL1/CXCL8 and CXCL16 have been well described to 
recruit neutrophils in vivo, while CXCL14 is considered a strong 
chemoattractant of neutrophils based on in vitro assays.25 27–30 
Interestingly, du Plessis et al previously described a correla-
tion between CXCL8 and liver inflammation or NAS, further 
strengthening the importance of this inflammatory protein 
in liver pathology.11 Furthermore, inhibition of CXCL14 was 
shown to reduce hepatic damage and mortality in a murine 
hepatotoxicity model. However, hepatic immune cell infiltra-
tion was not investigated.31 Interestingly, Wehr et al showed 
that inhibition of CXCL16 reduced macrophage infiltration in 
an inflammatory model of NASH.32 Unfortunately, neutrophil 
levels were not investigated in this study. In addition to gene 
expression data in specific ATM subsets, we also showed that AT 
from obese mice displays increased secretion of CXCL14 and 
CXCL16, while this secretion was blunted when ATMs were 
depleted. Thus, our data show that in addition to the increased 
numbers of CD11c+ cells in AT, obesity enhanced production of 
neutrophil chemotaxis proteins in these cells.
Previous human studies found associations between liver 
histopathology and ATMs in general, but did not investigate 
CD11c+ and CD11c− cells separately.11 12 To discriminate 
between these macrophage subsets, we used CD11c expres-
sion as a marker of CD11c+ macrophages (M1) and MRC1 
expression as a marker of CD11c− macrophages (M2). Our 
data show that AT expression of CD11c, but not of MCR1, 
correlated with neutrophil and macrophage markers in the 
livers of the same subjects. These data indicate that CD11c+ 
(M1) and not CD11c− (M2) ATMs are associated with liver 
pathology in humans. This notion is in agreement with find-
ings of du Plessis et al showing that CD11c+ cells are more 
frequent in AT from patients with NASH compared with 
non-NASH patients and are of vital importance in NAFLD 
to NASH progression.11 Our human data also confirmed the 
data of sorted cell murine ATMs showing higher expression 
of neutrophil chemotaxis genes in CD11c+ macrophages 
after HFD feeding. The expression of the CXCL chemokine 
family, which has similar functions regarding neutrophil 
chemotaxis in humans, correlated strongly with CD11c but 
not with MRC1 expression in AT. Moreover, the expression 
of the chemoattractant genes, CXCL5, CXCL16 and M-CSF, 
was elevated in the AT of patients who are obese with NASH 
compared with obese subjects without NASH. Our microarray 
data from human tissues also revealed some other genes 
that may be relevant to NAFLD in humans. In AT, CXCL2 
and CXCL5, both involved in neutrophil recruitment and 
homeostasis, correlated with CD11c expression.33–35 Interest-
ingly, there was also a strong correlation between CD11c and 
S100A8 in our human AT data, corresponding with data from 
Nagareddy et al describing higher levels of S100A8 and A9 in 
AT of obese mice when compared with AT of lean mice.26 The 
S100 protein family has been implicated in neutrophil recruit-
ment and more specifically the S100A8/9-TLR4 axis was 
shown to be involved in ATM-induced myelopoiesis.26 36 37 
Table 2 Correlations of CD11c and MRC1 expression with neutrophil chemotaxis genes in human vAT
CXCl2 (vAT) CXCl5 (vAT) CXCl8 (vAT) CXCl16 (vAT) s100A8 (vAT) G-CsF (vAT) GM-CsF(vAT) M-CsF (vAT)
CD11c (vAT) R value 0.695* 0.565* 0.736* 0.504* 0.813* 0.702* −0.016 0.069
p Value 0.000 0.000 0.000 0.000 0.000 0.000 0.895 0.559
MRC1 (vAT) R value 0.048 −0.032 0.046 0.024 0.008 0.092 0.030 0.045
p Value 0.685 0.787 0.696 0.838 0.943 0.435 0.798 0.701
R values and corresponding p values of the Pearson’s correlations between CD11c and MRC1 with CXCL2, CXCL5, CXCL8, CXCL16, S100A8, G-CSF, GM-CSF and M-CSF in vAT. 
n=74.
*p≤0.004 was deemed statistically significant due to adjustment for multiple testing.
vAT, visceral adipose tissue.
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Our findings are in agreement with the notion that neutrophil 
chemotaxis proteins are being expressed by human CD11c+ 
ATMs. Together with our experimental results in mice, these 
results suggest that CD11c+ ATMs contribute to neutrophil 
recruitment to the liver.
In our long-term murine experiment, hepatic macrophage 
content was increased after transplanting AT from obese mice. 
However, this was not paralleled by an increase in circulating 
monocytes or neutrophils after 8 weeks. Remarkably, we even 
noted a significant decrease in monocytes after transplanta-
tion of AT from obese mice which was not seen in the mice 
transplanted with ATM-depleted AT. Possibly, this decrease in 
circulating monocytes reflects enhanced hepatic recruitment, 
followed by their differentiation into tissue macrophages. In 
addition, since all mice received HCD already before performing 
AT transplantation, circulating monocyte levels were already 
high at baseline. This high baseline level of circulating mono-
cytes might explain why we did not observe monocytosis after 
AT transplantation, in contrast with the findings of Nagareddy 
et al.26 Finally, the effects of the transplanted AT on circulating 
cells and BM may be primarily acute and therefore might have 
been no longer present after 8 weeks.18 19 This reasoning is 
strengthened by the fact that we did see increases in monocytes 
and neutrophils 2 weeks post-transplantation. Differences with 
the study of Nagareddy et al may be explained by location of 
the transplanted AT. In our study, AT was transplanted into the 
peritoneal cavity while Nagareddy et al transplanted AT into 
the subcutaneous space.26 By transplanting AT to the parietal 
peritoneum, portal venous drainage of the transplanted AT was 
prevented in our study. Portal drainage of AT grafts has effects 
on insulin sensitivity, potentially via portal migration of cells or 
cytokines to the liver.9 Indeed, we did not detect any differences 
between groups in plasma glucose or insulin levels. Therefore, 
our results point to a systemic effect of the ATMs independent 
from direct drainage into the portal vein. Unfortunately, our 
model for NASH, the ldlr-/- mouse fed an HCD, did not allow us 
to investigate other relevant parameters of NASH. This model 
is excellent for rapidly inducing steatosis and inflammation, but 
fibrosis is mild and hepatocyte damage characterised by hepato-
cyte ballooning is limited.13 14
An important limitation in our human study is intrinsic to the 
statistical method employed which can only show associations 
and is not able to determine causality. Therefore, we can merely 
state that a change in CD11c expression in AT is associated with 
expression changes in macrophage or neutrophil genes in liver 
or neutrophil chemotaxis genes in AT. Protein levels or FACS-
sorted individual cell populations were also not obtained from 
human AT and therefore we were limited to gene expression 
data, which does not always show a clear relation with protein 
levels. Therefore, causal relationships can only be assumed based 
on our murine data. Prospective studies are needed to fully 
elucidate the contribution of CD11c+ macrophages to NASH 
progression. However, these studies prove to be challenging to 
perform as they would require multiple AT and liver biopsies. 
Therefore, we are currently limited to studies such as our own 
which can only reveal associations.
In conclusion, obesity induces accumulation of CD11c+ 
macrophages in AT, which produce more neutrophil regulatory 
and stimulating proteins resulting in elevated circulating neutro-
phil levels. The resulting hepatic neutrophil infiltration might 
lead to enhanced macrophage accumulation and contribute to 
NASH development. As both the CXCL and S100 protein family 
consists of targetable proteins, further investigation into specific 
inhibitors is warranted.
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